[go: up one dir, main page]

PT3298139T - Method for reducing or inactivating viral and microbial content in the processes for the manufacture of pancreatin - Google Patents

Method for reducing or inactivating viral and microbial content in the processes for the manufacture of pancreatin

Info

Publication number
PT3298139T
PT3298139T PT167973189T PT16797318T PT3298139T PT 3298139 T PT3298139 T PT 3298139T PT 167973189 T PT167973189 T PT 167973189T PT 16797318 T PT16797318 T PT 16797318T PT 3298139 T PT3298139 T PT 3298139T
Authority
PT
Portugal
Prior art keywords
pancreatin
manufacture
processes
reducing
microbial content
Prior art date
Application number
PT167973189T
Other languages
Portuguese (pt)
Original Assignee
Scient Protein Laboratories Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scient Protein Laboratories Llc filed Critical Scient Protein Laboratories Llc
Publication of PT3298139T publication Critical patent/PT3298139T/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/94—Pancreatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/327—Peroxy compounds, e.g. hydroperoxides, peroxides, peroxyacids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/37—Digestive system
    • A61K35/39—Pancreas; Islets of Langerhans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/54—Mixtures of enzymes or proenzymes covered by more than a single one of groups A61K38/44 - A61K38/46 or A61K38/51 - A61K38/53
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Cell Biology (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
PT167973189T 2015-05-19 2016-05-19 Method for reducing or inactivating viral and microbial content in the processes for the manufacture of pancreatin PT3298139T (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201562163779P 2015-05-19 2015-05-19

Publications (1)

Publication Number Publication Date
PT3298139T true PT3298139T (en) 2021-11-05

Family

ID=78230867

Family Applications (1)

Application Number Title Priority Date Filing Date
PT167973189T PT3298139T (en) 2015-05-19 2016-05-19 Method for reducing or inactivating viral and microbial content in the processes for the manufacture of pancreatin

Country Status (3)

Country Link
DK (1) DK3298139T3 (en)
ES (1) ES2896244T3 (en)
PT (1) PT3298139T (en)

Also Published As

Publication number Publication date
DK3298139T3 (en) 2021-10-25
ES2896244T3 (en) 2022-02-24

Similar Documents

Publication Publication Date Title
EP3119532A4 (en) Treated article and method of making the same
GB201507207D0 (en) Enzymes and applications thereof
EP3286142A4 (en) Liquid treatment system and method
EP3270909A4 (en) Fixed dose combinations comprising etc1002 and one or more statins for treating or reducing cardiovascular risk
EP3166615A4 (en) Methods for the treatment of hepatitis b and hepatitis d virus infections
IL247938A0 (en) Onconase for use in treating or preventing viral infections
IL258237A (en) Viral conjunctivitis treatment using ranpirnase and/or amphinase
EP3463324A4 (en) Levocetirizine and montelukast in the treatment of radiation-mediated conditions
EP3377085A4 (en) Peptides and methods of treating endometriosis using the same
PL3298139T3 (en) Method for reducing or inactivating viral and microbial content in the processes for the manufacture of pancreatin
PL3247651T3 (en) Container comprising treatment means and method for the production of same
GB2539474B (en) Glove and treatment method
GB201511799D0 (en) Composition and methods of treatment
EP3294392A4 (en) Nebulizers and uses thereof
PL3658174T3 (en) Lactoferricin and lactoferrampin for treating infections
IL250272A0 (en) Aglycosylated enzyme and uses thereof
SI4035687T1 (en) Method of genetic treatment using the virus aav-xbp1s/gfp, and its use in the prevention and treatment of amyotrophic lateral sclerosis
ZA201904328B (en) Composition, application thereof and treatment method
GB2558090B (en) Prevention and treatment for microbial infections
PT3298139T (en) Method for reducing or inactivating viral and microbial content in the processes for the manufacture of pancreatin
IL253418A0 (en) Nisin-based compounds and use thereof in the treatment of bacterial infections
GB201617715D0 (en) Methods for the treatment and prevention of ebola
HK40099982A (en) Means and methods for treating hbv
IL260410B (en) Puzzle set and method therefor
HK1257038A1 (en) Composition for treating and preventing viral infections